Home › Acute Lymphocytic Leukemia › California
Acute Lymphocytic Leukemia clinical trials in California
3 studies for Acute Lymphocytic Leukemia are looking for participants at sites in California.
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Pacific Cancer Medical Center, Inc, Anaheim
- TOI Clinical Research, Cerritos
- Stanford School of Medicine-Cancer Clinical Trials Office, Palo Alto
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05254743Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06580002Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
- City of Hope Comprehensive Cancer Center, Duarte
- Stanford University, Palo Alto
- UCSF (Benioff Children's), San Francisco
RecruitingObservational study
Up to age 26 · All sexes · Updated Jun 4, 2026 · NCT05865301From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.